Silo Pharma (SILO) Interest Coverage Ratio (2018 - 2026)
Silo Pharma (SILO) posted Interest Coverage Ratio of 10.24 for Q1 2026, up 73.43% sequentially from 38.56 in Q4 2025, and down 65.02% YoY from 29.28 in Q1 2025.
Silo Pharma (SILO) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Silo Pharma has reported Interest Coverage Ratio for 9 years, with the latest figure at 10.24 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 65.02% year-over-year to 10.24 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 30.71 (down 10.02% YoY) and the FY2025 annual result came in at 0.88, up 30.27% from the prior year.
- Interest Coverage Ratio advanced to 10.24 in Q1 2026 per SILO's latest filing, from 38.56 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.53 in Q2 2024 and troughed at 13807.98 in Q4 2022.
- A 5-year average of 1601.48 and a median of 11.03 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 71479833.34% in 2022, then surged 99.42% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 13807.98 in 2022, then soared by 69.13% to 4262.73 in 2023, then slumped by 55.25% to 6618.07 in 2024, then soared by 99.42% to 38.56 in 2025, then jumped by 73.43% to 10.24 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 10.24, 38.56, and 11.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | -324.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.32 |
| Mar 31, 2026 | -10.24 |
| Dec 31, 2025 | -38.56 |
| Sep 30, 2025 | -11.03 |
| Jun 30, 2025 | -7.59 |
| Mar 31, 2025 | -6.21 |
| Dec 31, 2024 | -6,618.07 |
| Sep 30, 2024 | -5.54 |
| Jun 30, 2024 | -0.53 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | -4,262.73 |
| Sep 30, 2023 | -77.42 |
| Jun 30, 2023 | -90.87 |
| Mar 31, 2023 | -4.79 |
| Dec 31, 2022 | -13,807.98 |
| Sep 30, 2022 | -528.48 |
| Jun 30, 2022 | -1,746.59 |
| Mar 31, 2022 | -7.41 |
| Dec 31, 2021 | -5,746.44 |
| Sep 30, 2021 | -7.93 |